TGFBR1 and ischemia: Specifically, induction of TGF-βR1 and downregulation of Let-7i following ischemia modulates inflammatory pathways in ECs, while increasing Let-7i with a TGF-βR1 antagonist reduced infarct volume and BBB permeability and improved neurological outcome [41].